BSE Live
Nov 21, 16:01Prev. Close
1456.60
Open Price
1455.10
Bid Price (Qty.)
1442.20 (3)
Offer Price (Qty.)
1458.35 (1)
NSE Live
Nov 21, 15:49Prev. Close
1455.30
Open Price
1460.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1451.80 (1)
| Cash Flow of Epigral (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 540.10 | 290.67 | 522.53 | 383.42 | 160.86 | |
| Net CashFlow From Operating Activities | 440.56 | 397.69 | 626.16 | 283.82 | 229.22 | |
| Net Cash Used In Investing Activities | -261.56 | -401.10 | -437.22 | -454.68 | -196.73 | |
| Net Cash Used From Financing Activities | -163.54 | -7.60 | -199.79 | 195.22 | -31.90 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 15.46 | -11.01 | -10.85 | 24.36 | 0.58 | |
| Cash And Cash Equivalents Begin of Year | 3.18 | 14.19 | 25.04 | 0.68 | 0.10 | |
| Cash And Cash Equivalents End Of Year | 18.64 | 3.18 | 14.19 | 25.04 | 0.68 |
14.11.2025
Epigral Consolidated September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
11.11.2025
Epigral Standalone September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
05.08.2025
Epigral Consolidated June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
05.08.2025
Epigral Standalone June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y